Publications
389
Citations
14,760
Est. group size
—
Recurring co-author estimate
Active years
61
Publishing since 1966
Joshua S. Davis conducts clinical infectious diseases research focused on bacterial infections such as Staphylococcus aureus bloodstream infections, prosthetic joint infections, and antibiotic treatment strategies. Much of the work involves large randomized controlled trials and systematic reviews evaluating antibiotic choice, treatment duration, and outcomes for serious bacterial infections. This research is highly clinically oriented, aimed at informing treatment guidelines for hospital-acquired and orthopedic-related infections.
Publication output has grown substantially over the past decade, rising from under 20 papers per year in 2017-2018 to a peak of over 40 per year in 2022-2024, with a mean of about 32 publications per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Duration of Therapy for <i>Pseudomonas aeruginosa</i> Bacteremia—A Post Hoc Subgroup Analysis From the BALANCE Randomized Controlled Trial
Clinical Infectious Diseases · 2026
- Application of a Novel Desirability of Outcome Ranking Endpoint Incorporating a Framework for Resistance Assessment and Microbiologic Evaluation in Antibiotic Trials: A Proof-of-Concept in a Post Hoc Analysis of the BALANCE Trial
Open Forum Infectious Diseases · 2026
- Communicable episode 45: top infectious diseases papers in 2025
CMI Communications · 2026
- Communicable episode 52: ESCMID Global Trials – PETER PEN and ASTARTÉ
CMI Communications · 2026
- A review of the randomized clinical trial results from the <i>Staphylococcus aureus</i> network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa
Journal of Antimicrobial Chemotherapy · 2026
- Cefazolin vs. antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis
Clinical Microbiology and Infection · 2025
- Effector T cells under hypoxia have an altered transcriptome similar to tumor-stressed T cells found in non-responsive melanoma patients
Journal for ImmunoTherapy of Cancer · 2025
- Advancing the management of prosthetic joint infections: a review of randomized controlled trials and emerging evidence
Antimicrobial Agents and Chemotherapy · 2025
- 2025 ICM: One-Stage Exchange
The Journal of Arthroplasty · 2025
- Facilitating Mental Health Disclosure and Better Work Outcomes: The Role of Organizational Support for Disclosing Mental Health Concerns
Human Resource Management · 2025
- Long-Term Mortality Associated with Periprosthetic Infection in Total Hip Arthroplasty
Journal of Bone and Joint Surgery · 2025
- Bacterial and fungal infections in persons who inject drugs
Clinical Microbiology Reviews · 2025
- Prevalence of Antibiotic Prescribing for Acute Respiratory Tract Infection in Telehealth Versus Face-to-Face Consultations: Cross-Sectional Analysis of General Practice Registrars’ Clinical Practice
Journal of Medical Internet Research · 2025
- Selective digestive tract decontamination in the intensive care unit: Life saver or recipe for disaster?
CMI Communications · 2025
- Comparison of surgical treatments for hip and knee periprosthetic joint infections using the desirability of outcome ranking in a prospective multicentre study
Journal of Bone and Joint Infection · 2025
- Open Forum Infectious Diseases×17
- The Medical Journal of Australia×15
- Clinical Infectious Diseases×14
- Clinical Microbiology and Infection×13
- CMI Communications×11
- Razieh Kebriaei
Medicine · The Ohio State University
- Joany Van Balen
Medicine · The Ohio State University
- Ching Yang
Medicine · The Ohio State University
- Christopher P. Montgomery
Medicine · The Ohio State University
- George A. Naclerio
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile